Site identity card

Centre Hospitalier Régional et Universitaire de Nancy

Nancy, France
Share

Networks

Clinical Studies (3)

  • IMACovid : Study aims to identify and characterize cardiac injury in post COVID patients as an ischemic or non-ischemic pattern, to better assess risk stratification and to guide effective therapies if necessary
  • COCOPREV : Study aims to analyze the impact of three monoclonal antibody therapies on the genetic evolution of the S gene in high-risk COVID-19 patients by employing next-generation sequencing to detect viral population changes and minority variants emergence
  • Co-SURVIVORS : Study aims to conduct a multidisciplinary assessment of respiratory, cardiac, sleep, and mental health sequelae three months after SARS-CoV-2 diagnosis in order to better characterise these complications

Study Data

  • Adults
  • General population
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Acute COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to